Search alternatives:
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
-
19221
Effect of environmental factors on the germination of Megathyrsus maximus: an invasive weed in sugarcane in Argentina
Published 2021“…Both mean germination percentages and CG decreased as osmotic potential became increasingly negative (0 MPa to -0.6 MPa), and as sodium chloride solution concentrations increased (10 to 130 mmol L-1). …”
-
19222
The effects of purmorphamine and Msi1 knockdown on p21<sup>CIP1,WAF1</sup> and c-Myc expression.
Published 2013“…Purmorphamine treatment decreased and increased the expression of p21<sup>CIP1,WAF1</sup> (<b>A</b>) and c-Myc (<b>B</b>), respectively. …”
-
19223
-
19224
-
19225
-
19226
-
19227
-
19228
-
19229
-
19230
Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain
Published 2024“…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
-
19231
-
19232
Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts
Published 2012“…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”
-
19233
-
19234
-
19235
-
19236
-
19237
-
19238
-
19239
-
19240